Page last updated: 2024-12-08

phacolysin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phacolysin: cpd not in Chemline 7/14/83; RN in 9th CI Form Index for 5,12-dihydroquinoxalino(2,3-b)phenazine-2,9-disulfonic acid (phacolysin in Negwer, 5th ed, #3514; MF=C18H12N4O6S2): 1790-56-3; different structure given for phacolysin in UD 24:43a (C21H17NO6S2) than in Negwer, 5th ed, #3514 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID165166
MeSH IDM0088631

Synonyms (27)

Synonym
AC-1537
quinoxalino(2,3-b)phenazine, 5,12-dihydro-, sulfonate, sodium salt (1:2:2)
jing ming
phacolysine
sodium 5,12-dihydroazapentacene disulfonate
quinax
3863-80-7
77883-76-2
phacolin
phacolysin
58b6f1x64h ,
unii-58b6f1x64h
AKOS015951394
AKOS015961917
FT-0673662
phacolysine sodium salt
disodium 5,14-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
azapentacene disulfonate disodium
azapentacen [who-dd]
quinoxalino(2,3-b)phenazine-2,9-disulfonic acid, 5,12-dihydro-, disodium salt
sodium 5,12-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
Q9257738
disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate
azapentacene sulfonate sodium
Q27261582
DTXSID90959472
sodium 5,14-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (58.33)18.7374
1990's4 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.53 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.23 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (28.57%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (64.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]